Internal medicine, Endocrinology, Thyrotropin receptor, Receptor and Thyroid are his primary areas of study. His Internal medicine research incorporates elements of Virus and Antibody. As a member of one scientific family, Yuji Nagayama mostly works in the field of Endocrinology, focusing on IL-2 receptor and, on occasion, T lymphocyte.
The study incorporates disciplines such as Epitope, Molecular biology, Protein subunit and Biochemistry in addition to Thyrotropin receptor. His Receptor research is multidisciplinary, incorporating perspectives in Monoclonal antibody, Site-directed mutagenesis and Pathogenesis. Yuji Nagayama has included themes like Apoptosis, Cancer research and In vitro in his Thyroid study.
Yuji Nagayama spends much of his time researching Internal medicine, Endocrinology, Thyroid, Immunology and Thyrotropin receptor. The various areas that Yuji Nagayama examines in his Internal medicine study include Gastroenterology and Antibody. In Endocrinology, Yuji Nagayama works on issues like IL-2 receptor, which are connected to T lymphocyte.
His research investigates the connection with Thyroid and areas like Cancer research which intersect with concerns in Thyroid carcinoma, Carcinogenesis, Suicide gene, Genetic enhancement and In vivo. As a part of the same scientific family, Yuji Nagayama mostly works in the field of Immunology, focusing on Graves' disease and, on occasion, Immune tolerance, Euthyroid, Anti-thyroid autoantibodies and BALB/c. His Thyrotropin receptor research includes elements of Receptor, Biochemistry, Ectodomain, Molecular biology and Epitope.
His main research concerns Thyroid, Thyroid cancer, Cancer research, Internal medicine and Cancer. His biological study spans a wide range of topics, including Carcinogenesis, Extracellular and Adenoma. Yuji Nagayama has researched Thyroid cancer in several fields, including Cancer stem cell and Thyroid peroxidase.
His Internal medicine study frequently draws connections to adjacent fields such as Endocrinology. His research in Endocrinology intersects with topics in Immunohistochemistry, Receptor and Autoimmunity. His Receptor research includes themes of Graves' disease, Antibody and Immune system.
His scientific interests lie mostly in Thyroid cancer, Molecular biology, Cancer, Cancer research and Cancer stem cell. His Thyroid cancer research entails a greater understanding of Thyroid. He combines subjects such as DNA damage, Genome instability, DNA synthesis, DNA repair and LIG4 with his study of Molecular biology.
In the field of Internal medicine and Endocrinology Yuji Nagayama studies Papillary thyroid cancer. The concepts of his Internal medicine study are interwoven with issues in Antibody and Immune system. Yuji Nagayama is involved in the study of Endocrinology that focuses on Graves' disease in particular.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Differences and Similarities in the Diagnosis and Treatment of Graves' Disease in Europe, Japan, and The United States
Leonard Wartofsky;Daniel Glinoer;Barbara Solomon;Shigenobu Nagataki.
The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim
Chun-Rong Chen;Pavel Pichurin;Yuji Nagayama;Francesco Latrofa.
Journal of Clinical Investigation (2003)
A Novel Murine Model of Graves’ Hyperthyroidism with Intramuscular Injection of Adenovirus Expressing the Thyrotropin Receptor
Yuji Nagayama;Masako Kita-Furuyama;Takao Ando;Kazuhiko Nakao.
Journal of Immunology (2002)
Malfunction of Nuclease ERCC1-XPF Results in Diverse Clinical Manifestations and Causes Cockayne Syndrome, Xeroderma Pigmentosum, and Fanconi Anemia
Kazuya Kashiyama;Yuka Nakazawa;Daniela T. Pilz;Chaowan Guo.
American Journal of Human Genetics (2013)
Cloning and tissue distribution of novel splice variants of the rat GABAB receptor.
Shojiro Isomoto;Muneshige Kaibara;Yasuko Sakurai-Yamashita;Yuji Nagayama.
Biochemical and Biophysical Research Communications (1998)
Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide
Yasuhide Motoyoshi;Kazuhisa Kaminoda;Ohki Saitoh;Keisuke Hamasaki.
Oncology Reports (2006)
An insertion in the human thyrotropin receptor critical for high affinity hormone binding.
Harry L. Wadsworth;Gregorio D. Chazenbalk;Yuji Nagayama;Diego Russo.
A monoclonal thyroid-stimulating antibody
Takao Ando;Rauf Latif;Alla Pritsker;Thomas Moran.
Journal of Clinical Investigation (2002)
Ontogenetic Changes in the Expression of Estrogen Receptor α and β in Rat Pituitary Gland Detected by Immunohistochemistry
Eijun Nishihara;Yuji Nagayama;Satoshi Inoue;Hisahiko Hiroi.
Schistosoma mansoni and α-Galactosylceramide: Prophylactic Effect of Th1 Immune Suppression in a Mouse Model of Graves’ Hyperthyroidism
Yuji Nagayama;Kanji Watanabe;Masami Niwa;Sandra M. McLachlan.
Journal of Immunology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: